Elite Pharmaceuticals, Inc. (ELTP) Financials - Complete Data

Elite Pharmaceuticals, Inc. ELTP: $0.0469

, , , . | Sector: Manufacturing | Exchange: OTCQB MARKETPLACE | Web:

Elite Pharmaceuticals, Inc. (ELTP) Full Financials Data

Gross Profit$1,865,941
Cost of Revenue$2,529,590
Operating Revenue$4,395,531
Total Revenue$4,395,531
Operating Income-$1,067,503
Net Income-$482,623
R & D$1,775,255
Operating Expense$5,463,034
Current Assets$12,194,667
Total Assets$26,189,492
Total Liabilities$10,037,563
Current Cash$3,192,768
Current Debt$410,818
Short-term Debt$410,818
Long-term Debt$1,740,734
Total Cash$3,192,768
Total Debt$2,151,552
Shareholder Equity$16,151,929
Cash Change$3,192,768
Cash Flow-$749,368

Elite Pharmaceuticals, Inc. (ELTP) Key Stats

Employees43
Moving Average (200 Days)$0.0569
Moving Average (50 Days)$0.0496
Float0
Avg Volume (10 Days)528,378
Avg Volume (30 Days)612,303
EPS TTM$0.0054
Dividend Rate (TTM)0
Dividend Yield0
Last Dividend Date
PE Ratio9.460110047655256
Beta0.000
1 Yr Change -24%
This Yrs' Change -9%
6 Mnths' Change -24%
3 Months' Change-15%
30 Days Change -3%
5 Days Change -2%
Max Change -80%

Latest News About Elite Pharmaceuticals, Inc.